These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33047569)

  • 1. [Analysis of Quality Management of
    Lyu M; Bai D; Chen L; Luo J
    Zhongguo Yi Liao Qi Xie Za Zhi; 2020 Oct; 44(5):436-438. PubMed ID: 33047569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A pilot study on the quality management system of in-vitro diagnostic reagents].
    Liu X; Huang JH; Xu FL; Wang Z; Gu WK
    Zhongguo Yi Liao Qi Xie Za Zhi; 2006 May; 30(3):199-205. PubMed ID: 16929780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Refined Management of the Second Class Warehouse and Cost-benefit Analysis for In-vitro Diagnostic Reagent].
    Tang G; Hu L; Xu H; Fang Z
    Zhongguo Yi Liao Qi Xie Za Zhi; 2016; 40(4):308-10. PubMed ID: 29775534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on administration of in-vitro diagnostic reagents].
    Wang Z; Qian H; Xu FL; Huang JH; Gu WK
    Zhongguo Yi Liao Qi Xie Za Zhi; 2005 Mar; 29(2):124-30. PubMed ID: 16011119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of Class II Common Problems in the Registration of
    Yang X; Dong Q; Zhu W; Zhen H
    Zhongguo Yi Liao Qi Xie Za Zhi; 2020 Dec; 44(6):537-540. PubMed ID: 33314864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [WHO in Vitro Diagnostic Reagent Products Prequalification Program].
    Lv H
    Zhongguo Yi Liao Qi Xie Za Zhi; 2016; 40(4):275-8. PubMed ID: 29775524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A microcomputer program for reagent cost management.
    Adair B; Darling D
    MLO Med Lab Obs; 1987 Aug; 19(8):87, 89. PubMed ID: 10283537
    [No Abstract]   [Full Text] [Related]  

  • 8. Premature degradation of Abbott TDx reagents.
    Bacaj PJ; Boyd JC; Herold DA
    Clin Chem; 1990 May; 36(5):818. PubMed ID: 2338000
    [No Abstract]   [Full Text] [Related]  

  • 9. Choosing an IVD notified body: start now and gain a competitive edge.
    Suppo M
    Med Device Technol; 1998; 9(6):28-30. PubMed ID: 10182123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Discussion about Management of In Vitro Diagnostic Reagent].
    Huang L; Zhu J; Gu H; Geng Y
    Zhongguo Yi Liao Qi Xie Za Zhi; 2015 Mar; 39(3):232-4. PubMed ID: 26524796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on FDA regulation of in vitro diagnostic devices.
    Gutman S; Richter K; Alpert S
    JAMA; 1998 Jul; 280(2):190-2. PubMed ID: 9669798
    [No Abstract]   [Full Text] [Related]  

  • 12. [Discussion on Management Model of Medical Devices for Clinical Trials].
    Chen B; Wu J; Hu H; Yang X; Huang J
    Zhongguo Yi Liao Qi Xie Za Zhi; 2020 Jan; 44(1):88-91. PubMed ID: 32343076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are current regulations for approval of in vitro diagnostic devices adequate?
    Levine D; Grossberg R; Tilton R; Banks P; Rosenfeld A
    JAMA; 1998 Jul; 280(2):187-9. PubMed ID: 9669797
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA issues final rule for classification and reclassification of immunochemistry reagents and kits.
    Taylor CR
    Am J Clin Pathol; 1999 Apr; 111(4):443-4. PubMed ID: 10191763
    [No Abstract]   [Full Text] [Related]  

  • 15. Revised recommendation (1983) on evaluation of diagnostic kits. Part 2. Guidelines for the evaluation of clinical chemistry kits.
    Logan JE
    J Clin Chem Clin Biochem; 1983 Dec; 21(12):899-902. PubMed ID: 6663250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research on the Whole-process Cloud Monitoring Mode of
    Mao Y; Ding J; Ren W; Zhu Q; Zhang Y; Xie M
    Zhongguo Yi Liao Qi Xie Za Zhi; 2019 May; 43(3):205-208. PubMed ID: 31184080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commutability limitations influence quality control results with different reagent lots.
    Miller WG; Erek A; Cunningham TD; Oladipo O; Scott MG; Johnson RE
    Clin Chem; 2011 Jan; 57(1):76-83. PubMed ID: 21097677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of reagent evaporation on other laboratory reagents and appropriate countermeasures].
    Sato T; Tani K; Yoshimura H; Sakurabayashi I
    Rinsho Byori; 2003 Sep; 51(9):864-8. PubMed ID: 14560654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Field evaluation of a novel differential diagnostic reagent for detection of Mycobacterium bovis in cattle.
    Cockle PJ; Gordon SV; Hewinson RG; Vordermeier HM
    Clin Vaccine Immunol; 2006 Oct; 13(10):1119-24. PubMed ID: 16943346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.